Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Monsanto Company (MON), JPMorgan Chase & Co (JPM): Why Today’s Flat Market Is Good News for Long-Term Investors

Although we don’t believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes — just in case they’re material to our investing thesis.

Today’s news that job growth in the U.S. was weaker than economists had hoped is dragging on the stock market, and at first glance, that might seem like bad news for bullish investors. But what’s particularly encouraging is that stock investors are once again reconnecting their prospects with growth in the U.S. economy. That’s a welcome change from the “bad news is good news” paradigm that we saw in the recent past, where stocks would rally on hopes that the Federal Reserve would keep taking new stimulative measures in an effort to hasten the pace of the economic recovery. Despite this morning’s loss in the Dow Jones Industrial Average 2 Minute (INDEXDJX:.DJI), which is flat as of 11 a.m. EDT, having recovered from steep losses, investors are showing signs that they understand where long-term share-price appreciation will come from.

Monsanto Company (NYSE:MON)

Nevertheless, many individual Dow Jones Industrial Average 2 Minute (INDEXDJX:.DJI) components are falling after the employment news. E I Du Pont De Nemours And Co (NYSE:DD) is down 0.9%, as the company could face opposition from customers as it moves to focus more on its agribusiness segment. Yesterday, rival Monsanto Company (NYSE:MON) got the bad news that farmers and others who have challenged its patented crops will appeal to the U.S. Supreme Court after their move to prevent Monsanto Company (NYSE:MON) from suing them for accidental use of its seeds was rejected by an appeals court. Similar issues could plague E I Du Pont De Nemours And Co (NYSE:DD) in the future if it becomes more reliant on seed designs of its own.

UnitedHealth Group Inc. (NYSE:UNH) is flatlining after the release of a study earlier this week from the Kaiser Family Foundation judged that insurance costs under Obamacare would be affordable. The survey looked at 17 different states, examining the best-available premium rates for a couple of different coverage options for residents of various ages. For UnitedHealth Group Inc. (NYSE:UNH), the key to success will be getting people of all ages to buy policies in compliance with Obamacare so as to broaden its risk pool to the largest extent possible. The biggest threat to UnitedHealth Group Inc. (NYSE:UNH) and its peers would be if the healthiest people chose not to get coverage, leaving insurers with higher costs and potential premium increases that could sour their public perception.

Finally, JPMorgan Chase & Co (NYSE:JPM) stock has slipped after the company decided to stop offering student loans. Even as student debt has exploded higher in recent years, the desirability of student loans from the banking sector’s perspective has fallen substantially because of the removal of government guarantees on private loans. With a higher risk profile, JPMorgan Chase & Co (NYSE:JPM) apparently believes that other types of lending represent a better risk-reward proposition.


The article Why Today’s Flat Market Is Good News for Long-Term Investors originally appeared on is written by Dan Caplinger.

Fool contributor Dan Caplinger owns warrants on JPMorgan Chase. You can follow him on Twitter @DanCaplinger. The Motley Fool recommends UnitedHealth Group (NYSE:UNH). The Motley Fool owns shares of JPMorgan Chase. 

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!